Clever Culture Systems
 

« Previous article
How AI is Changing C...

29th October 2024  Content supplied by: Clever Culture Systems

LBT Announces Bristol Myers Squibb Become First US Pharma Giant to Adopt APAS® Independence


Australian medical technology company LBT Innovations Limited has successfully sold its APAS® Independence instrument to pharmaceutical giant Bristol Myers Squibb in the United States. This landmark sale marks LBT's first foray into the US pharmaceutical market, signaling a significant expansion of its artificial intelligence-driven microbiology automation technology.

The sale, completed within an impressive three-month timeframe, comes as part of Bristol Myers Squibb's ongoing evaluation of the APAS® Independence, which began in the September 2024 quarter. This rapid progression from evaluation to purchase underscores the compelling value proposition of LBT's cutting-edge technology in the pharmaceutical industry.

Download the full press release here.


Share on:

Tags:


Date Published: 29th October 2024

Source article link: View


View full company details